Raloxifene HCL Research Overview
Raloxifene hydrochloride is a selective estrogen receptor modulator (SERM) belonging to the benzothiophene class of compounds. This research-grade formulation from OSR Healthcare delivers precisely 60mg of raloxifene HCL per tablet, manufactured under rigorous quality standards for laboratory investigation. Researchers at Stroid UK Shop study raloxifene’s unique tissue-selective properties, examining its dual mechanism as an estrogen receptor antagonist in breast tissue while functioning as an agonist in bone and cardiovascular systems in preclinical models.
Laboratory Research Applications
In controlled laboratory environments, raloxifene demonstrates distinctive pharmacological characteristics that differentiate it from other SERMs. Research teams investigate its competitive binding affinity at estrogen receptors, with particular focus on its ability to modulate gene transcription in tissue-specific contexts. Unlike compounds in the SARM category, raloxifene operates through estrogen receptor pathways, making it valuable for comparative studies examining different hormonal modulation mechanisms. The compound’s oral bioavailability and metabolic profile provide researchers with insights into selective estrogen receptor modulation that complement studies with peptide-based modulators. Scientists analyse raloxifene’s effects on bone mineral density markers, lipid metabolism parameters, and endometrial proliferation in various research protocols.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Raloxifene Hydrochloride |
| CAS Number | 82640-04-8 |
| Molecular Formula | C₂₈H₂₈NO₄S·HCl |
| Molecular Weight | 510.05 g/mol |
| Tablet Strength | 60mg |
| Manufacturer | OSR Healthcare |
| Storage Conditions | Room temperature, dry environment |
| Classification | Selective Estrogen Receptor Modulator |
Each tablet contains precisely measured raloxifene HCL content suitable for accurate research dosing calculations. The formulation maintains stability under standard laboratory storage conditions, enabling consistent research outcomes across extended study periods. Researchers studying compounds in the broader aromatase inhibitor and SERM category frequently utilise raloxifene as a reference standard for comparative tissue selectivity analyses.
Research-Only Compliance Statement
This raloxifene hydrochloride formulation is manufactured exclusively for in-vitro laboratory research applications. The compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure proper handling protocols, maintain appropriate documentation, and comply with institutional research guidelines when studying this selective estrogen receptor modulator.
